Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker discovery for renal cancer stem cells

18 Dec 2017

Abstract excerpt

Abstract Characterised by high intra‐ and inter‐tumor heterogeneity, metastatic renal cell carcinoma (RCC) is resistant to chemo‐ and radiotherapy. Therefore, the development of new prognostic and diagnostic markers for RCC patients is needed. Cancer stem cells (CSCs) are a small population of neoplastic cells within a tumor which present characteristics reminiscent of normal stem cells. CSCs are characterised by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29416873
DOI: 10.1002/cjp2.91

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker discovery for renal cancer stem cellsPMID 29416873Read ↗

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cellsSemantic proximity Read ↗

CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challengesSemantic proximity Read ↗

Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug DevelopmentSemantic proximity Read ↗

Stemness-related markers in cancerSemantic proximity Read ↗

Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetSemantic proximity Read ↗

Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysisSemantic proximity Read ↗

New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulationSemantic proximity Read ↗

CD133 as a Marker for Cancer Stem Cells: Progresses and ConcernsSemantic proximity Read ↗

Identification of Prognostic Stemness-related Genes in Kidney Renal Papillary Cell CarcinomaSemantic proximity Read ↗

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinomaSemantic proximity Read ↗

BCSCdb: a database of biomarkers of cancer stem cellsSemantic proximity Read ↗

CD44: a stemness driver, regulator, and marker—all in one?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.